Candy Prijs
CANDYDeze cryptocurrency is niet beschikbaar voor handel of diensten op Gate.
Candy (CANDY) Prijs Live Grafiek
Candy (CANDY) Prijs Vandaag
De prijs van Candy (CANDY) is vandaag $0.00000003027, met een 24-uurs handelsvolume van $7.56. Hierdoor heeft Candy (CANDY) een marktkapitalisatie van --, wat neerkomt op een marktdominantie van 0.00000047%. De prijs van Candy (CANDY) is de afgelopen 24 uur met -- veranderd.
CANDY Prijsgegevens
- 24u Omzet$7.56
- All Time High (ATH)$0.00000217
- 24u hoog$0.00000003027
- All-Time Low (ATL)$0.00000001737
- 24u Laag$0.00000003027
CANDY Marktkapitalisatie-info
- Volledig verwaterde waardering$12.73K
- MarktsentimentNeutraal
CANDY Aanbod
- Totale voorraad420.69B CANDY
- Maximale voorraad420.69B CANDY
*Gegevens zijn alleen ter referentie
Over Candy (CANDY)
Contract
0x33b7f62...5b18b8c2b
Verkenners
basescan.org
Website
basedcandy.vip
Community
Tags
Peep this meme with blonde locks and lucious meme-able style, Candy is Andy's Girlfriend.
Candy is a meme-coin on the base network, we created this hot girl token for all the men on the network to simp over, top quality memes and experienced team from a 28m previous project. Exposure is key.
- GateNewsPi Network will launch its V23 upgrade next month, featuring smart contracts, a DApp ecosystem, and a decentralized exchange. With over 18 million KYC-verified users, this upgrade moves Pi towards practical applications and utility in its ecosystem.
- GateNewsGate News: According to the latest Gate TradFi data, MINIMAX (MINIMAX-W 00100.HK) has surged by 6% in a short period. Current volatility is significantly higher than recent averages, indicating increased market
- GateNewsThe Sentinel Action Fund, supported by the Solana Foundation, will invest $8 million to aid Republican Senator Jon Husted in the Ohio Senate race against Sherrod Brown, who opposes crypto. Husted is known for advocating pro-crypto legislation.
- GateNewsNovo Nordisk has partnered with OpenAI to enhance drug development and AI integration in operations. The collaboration aims to speed up drug candidate analysis and employee training, potentially transforming obesity and diabetes research and beyond.
